Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation

Archives of Surgery

Volumn 138, Issue 10, 2003, Pages 1121-1126

  Freise, Chris E ^a   Kang, Sang Mo ^b   Feng, Sandy ^b   Hirose, Ryo ^b   Stock, Peter ^b   Perez, Richard V ^b   Shackleton, Chris ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANEMIA; CLINICAL ARTICLE; DIARRHEA; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAINTENANCE THERAPY; MALE; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE;

ADULT; ANTILYMPHOCYTE SERUM; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SIROLIMUS; STEROIDS; TACROLIMUS; TREATMENT OUTCOME;

EID: 0141993059     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.138.10.1121     Document Type: Review

References (12)

1. Stratta J. Review of immunosuppressive usage in pancreas transplantation. Clin Transplant. 1999;13:1-12.
2. Kaufman DB, Leventhal JR, Stuart J, Abecassis MM, Fryer JP, Stuart FP. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to non-induction therapy with enteric drainage. Surgery. 2000;128:726.
3. Jordan ML, Chakrabarti P, Luke P, et al. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation. 2000;69:265-271.
4. Humar A, Parr E, Drangstveit M, Kandaswamy R, Gruessner A, Sutherland DER. Steroid withdrawal in pancreas recipients. Clin Transplant. 2000;14:75-78.
5. Witzigmann H, Rhein T, Geissler J, et al. Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results. Transplant Proc. 2002;34:3354-3356.
6. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in 7 patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
7. Freise CE, Narumi S, Stock PG, Meizer JS. Simultaneous pancreas-renal transplantation: overview of indications, complications and outcomes. West J Med. 1999;170:11-18.
8. Ringe B, Braun F, Schutz E, et al. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation. 2001;71:508-515.
9. Cole E, Landsberg D, Russell D, et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation. 2001;72:845-850.
10. Morrisett JD, Abdel-Fattah G, Hoogeveen R, et al. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res. 2002;43:1170-1180.
11. Kaufman DB, Leventhal J, Koffron A, et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation. Transplantation. 2002;73:169-177.
12. Lemieux I, Houde I, Pascot A, et al. Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney Int. 2002;62:1839-1847.